Marlio Charles Mosseri - Net Worth and Insider Trading

Marlio Charles Mosseri Net Worth

The estimated net worth of Marlio Charles Mosseri is at least $17 Million dollars as of 2024-05-16. Marlio Charles Mosseri is the 10% Owner of Nuvectis Pharma Inc and owns about 2,595,000 shares of Nuvectis Pharma Inc (NVCT) stock worth over $17 Million. Details can be seen in Marlio Charles Mosseri's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Marlio Charles Mosseri has not made any transactions after 2023-07-31 and currently still holds the listed stock(s).

Transaction Summary of Marlio Charles Mosseri

To

Marlio Charles Mosseri Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marlio Charles Mosseri owns 1 companies in total, including Nuvectis Pharma Inc (NVCT) .

Click here to see the complete history of Marlio Charles Mosseri’s form 4 insider trades.

Insider Ownership Summary of Marlio Charles Mosseri

Ticker Comapny Transaction Date Type of Owner
NVCT Nuvectis Pharma Inc 2023-07-31 10 percent owner

Marlio Charles Mosseri Latest Holdings Summary

Marlio Charles Mosseri currently owns a total of 1 stock. Marlio Charles Mosseri owns 2,595,000 shares of Nuvectis Pharma Inc (NVCT) as of July 31, 2023, with a value of $17 Million.

Latest Holdings of Marlio Charles Mosseri

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVCT Nuvectis Pharma Inc 2023-07-31 2,595,000 6.65 17,256,750

Holding Weightings of Marlio Charles Mosseri


Marlio Charles Mosseri Form 4 Trading Tracker

According to the SEC Form 4 filings, Marlio Charles Mosseri has made a total of 16 transactions in Nuvectis Pharma Inc (NVCT) over the past 5 years, including 16 buys and 0 sells. The most-recent trade in Nuvectis Pharma Inc is the acquisition of 860 shares on July 31, 2023, which cost Marlio Charles Mosseri around $11,937.

Insider Trading History of Marlio Charles Mosseri

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marlio Charles Mosseri Trading Performance

GuruFocus tracks the stock performance after each of Marlio Charles Mosseri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marlio Charles Mosseri is -30.73%. GuruFocus also compares Marlio Charles Mosseri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marlio Charles Mosseri within 3 months outperforms 0 times out of 16 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Marlio Charles Mosseri's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Marlio Charles Mosseri

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.11
Relative Return to S&P 500(%) -3.96

Marlio Charles Mosseri Ownership Network

Ownership Network List of Marlio Charles Mosseri

No Data

Ownership Network Relation of Marlio Charles Mosseri


Marlio Charles Mosseri Owned Company Details

What does Nuvectis Pharma Inc do?

Who are the key executives at Nuvectis Pharma Inc?

Marlio Charles Mosseri is the 10 percent owner of Nuvectis Pharma Inc. Other key executives at Nuvectis Pharma Inc include director & Chairman & CEO Ron Bentsur , Chief Development Officer Shay Shemesh , and Chief Science and Business Off Enrique Poradosu .

Nuvectis Pharma Inc (NVCT) Insider Trades Summary

Over the past 18 months, Marlio Charles Mosseri made 16 insider transaction in Nuvectis Pharma Inc (NVCT) with a net purchase of 202,124. Other recent insider transactions involving Nuvectis Pharma Inc (NVCT) include a net purchase of 22,315 shares made by Ron Bentsur , a net purchase of 2,333 shares made by Shay Shemesh , and a net purchase of 1,000 shares made by Enrique Poradosu .

In summary, during the past 3 months, insiders sold 0 shares of Nuvectis Pharma Inc (NVCT) in total and bought 10,553 shares, with a net purchase of 10,553 shares. During the past 18 months, 0 shares of Nuvectis Pharma Inc (NVCT) were sold and 227,772 shares were bought by its insiders, resulting in a net purchase of 227,772 shares.

Nuvectis Pharma Inc (NVCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nuvectis Pharma Inc Insider Transactions

No Available Data

Marlio Charles Mosseri Mailing Address

Above is the net worth, insider trading, and ownership report for Marlio Charles Mosseri. You might contact Marlio Charles Mosseri via mailing address: 27 Ripplevale Grove, London X0 N1 1hs.

Discussions on Marlio Charles Mosseri

No discussions yet.